NEW YORK, Nov. 22, 2016 /PRNewswire/ -- In this report, the Europe advance wound care market has been broadly classified on the basis of application, method, geography, and end-user. The application segment is divided into surgical wounds, ulcers, and other wounds, where ulcers are further segmented into diabetic foot ulcers, venous ulcers, pressure ulcers, and arterial ulcers. The method segment includes dressings and grafts, where dressings are further categorized into antimicrobial dressings, foam dressings, gauze, hydrocolloids collagen, film dressings, hydrogels, composites, alginate dressings; and grafts are further segmented into composite skin grafts and biologic grafts. Biologic grafts include autografts, allografts and xenografts. The geography segment includes Germany, U.K., Italy, France, Spain, Netherlands, Belgium, Austria, Switzerland and Rest of Europe (RoE). The end-user segment includes in-patient facilities and out-patient facilities.
The Europe advanced wound care market is a competitive market with a number of market players. As of 2014, this market is majorly dominated by Smith and Nephew, Plc. (U.K.), Molyncke Health Care (Sweden), and ConvaTec, Inc. (U.S.).
New product launches, partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most of the market players to achieve growth in this market.